Disetronic's first quarter grows nearly 20%:
This article was originally published in Clinica
Disetronic Medical Systems, the Swiss infusion and injection device company, saw its total sales rise 19.5% in the first quarter. Its infusion business grew by 24%, while injection systems rose by 28%. Total sales were SWFr69.9 million ($41 million). The Burgdorf company has just launched its D-Tron insulin pump in the US.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.